Grant of awards under Long-Term Incentive Plan

Summary by AI BETAClose X

Inspiration Healthcare Group plc announced on August 7, 2026, the grant of 2,759,141 options under its Long-Term Incentive Plan, including 1,822,268 awarded to the Chief Executive Officer and Chief Financial Officer. These options, exercisable at nil cost, are subject to vesting conditions tied to Adjusted EBITDA and cashflow conversion targets over the three years ending January 31, 2029. Additionally, bonus awards for the financial year ended January 31, 2026, were granted, vesting immediately and exercisable from the first anniversary of the award date. The Chief Executive Officer received 787,027 LTIP options and 308,756 bonus options, while the Chief Financial Officer received 494,918 LTIP options and 231,567 bonus options.

Disclaimer*

Inspiration Healthcare Group PLC
07 August 2026
 

 

 

7 August 2026

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Group" or the "Company")

                                                  

Grant of awards under Long-Term Incentive Plan

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, pioneering specialist neonatal intensive care medical devices, announces that on 6 August 2026, the Company awarded 2,759,141 options under the Inspiration Group plc Long Term Incentive Plan including 1,822,268 to its Chief Executive Officer and Chief Financial Officer as set out in the table below. The awards are over ordinary shares of £0.10 ("Ordinary Shares") in the form of options to acquire Ordinary Shares at nil cost ("Awards").

 

These awards reflect the annual issue of long term incentives and annual bonus awards under the Group's remuneration policy. The LTIP Awards will vest on the third anniversary of grant subject to meeting a minimum Adjusted EBITDA and Adjusted EBITDA to operating cashflow conversion targets over the three-year period ending on 31 January 2029. Bonus Awards relate to bonuses awarded for the financial year ended 31 January 2026 ("FY26"), vest immediately and can be exercised from the first anniversary of the award date.

 

Executive

Role

Number of Awards

Raffi Stepanian

Chief Executive Officer

787,027 LTIP

Raffi Stepanian

Chief Executive Officer

308,756 FY26 Bonus

Alan Olby

Chief Financial Officer

494,918 LTIP

Alan Olby

Chief Financial Officer

231,567 FY26 Bonus

 

For further information, please contact:

 

Inspiration Healthcare Group plc

Tel: +44 (0)330 175 0000

Raffi Stepanian, Chief Executive Officer

Alan Olby, Chief Financial Officer




Singer Capital Markets (Nominated Adviser & Broker)

Tel: +44 (0)20 7496 3000

Alex Bond


Patrick Weaver




Cavendish Capital Markets (Joint Broker)

Tel: + 44 (0)20 7220 0500

Giles Balleny / Joe Smith


Nigel Birks


Harriet Ward




Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com

Anna Dunphy

Mob: +44 (0) 7876 741 001

Rachel Broad

Mob: +44 (0) 7747 515 393

 

 

 

 

 

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

 

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

 

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

 

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

 

1. Details of the person discharging managerial responsibilities / person closely associated


a) Name

Harout Rafi Stepanian

2. Reason for the notification


a) Position/status

PDMR (Chief Executive Officer)

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor


a) Name

Inspiration Healthcare Group plc

b) LEI

213800GKFT3ENAPMDL15

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


a) Description of the financial instrument, type of instrument / Identification code

Options over Ordinary Shares of £0.10 each in the capital of the Company

ISIN: GB00BXDZL105

b) Nature of the transaction

Grant of options under the Inspiration Healthcare Group plc Long Term Incentive Plan

c) Price(s) and volume(s)

Price(s): Nil

Volume(s): 787,027

d) Aggregated information - Aggregated volume, Price

n/a

e) Date of the transaction

6 August 2026

f) Place of the transaction

Off market

 

1. Details of the person discharging managerial responsibilities / person closely associated


a) Name

Harout Rafi Stepanian

2. Reason for the notification


a) Position/status

PDMR (Chief Executive Officer)

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor


a) Name

Inspiration Healthcare Group plc

b) LEI

213800GKFT3ENAPMDL15

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


a) Description of the financial instrument, type of instrument / Identification code

Options over Ordinary Shares of £0.10 each in the capital of the Company

ISIN: GB00BXDZL105

b) Nature of the transaction

Grant of options in respect of the FY26 annual bonus award

c) Price(s) and volume(s)

Price(s): Nil

Volume(s): 308,756

d) Aggregated information - Aggregated volume, Price

n/a

e) Date of the transaction

6 August 2026

f) Place of the transaction

Off market

 

1. Details of the person discharging managerial responsibilities / person closely associated


a) Name

Alan Musgrave Olby

2. Reason for the notification


a) Position/status

PDMR (Chief Financial Officer)

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor


a) Name

Inspiration Healthcare Group plc

b) LEI

213800GKFT3ENAPMDL15

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


a) Description of the financial instrument, type of instrument / Identification code

Options over Ordinary Shares of £0.10 each in the capital of the Company

ISIN: GB00BXDZL105

b) Nature of the transaction

Grant of options under the Inspiration Healthcare Group plc Long Term Incentive Plan

c) Price(s) and volume(s)

Price(s): Nil

Volume(s): 494,918

d) Aggregated information - Aggregated volume, Price

n/a

e) Date of the transaction

6 August 2026

f) Place of the transaction

Off market

 

1. Details of the person discharging managerial responsibilities / person closely associated


a) Name

Alan Musgrave Olby

2. Reason for the notification


a) Position/status

PDMR (Chief Financial Officer)

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor


a) Name

Inspiration Healthcare Group plc

b) LEI

213800GKFT3ENAPMDL15

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


a) Description of the financial instrument, type of instrument / Identification code

Options over Ordinary Shares of £0.10 each in the capital of the Company

ISIN: GB00BXDZL105

b) Nature of the transaction

Grant of options in respect of the FY26 annual bonus award

c) Price(s) and volume(s)

Price(s): Nil

Volume(s): 231,567

d) Aggregated information - Aggregated volume, Price

n/a

e) Date of the transaction

6 August 2026

f) Place of the transaction

Off market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings